Your research can change the world
More on impact ›
Submit your manuscript
Scope
Radionuclide Therapy is a fast-growing area of nuclear medicine. The section aims to publish innovative clinical and preclinical research on new therapeutic options as well as clinical studies using established radiopharmaceuticals. Our intention is to make active and critical contributions to science discourses.
Scope
Radionuclide Therapy is an exciting and fast growing area in the field of Nuclear Medicine. Several new radiopharmaceuticals achieved approval in the last years and many new and exciting therapy options are under investigation. The Radionuclide Therapy section aims to publish innovative clinical and preclinical research on new therapeutic options as well as clinical studies using established radiopharmaceuticals. Areas covered by this section include, but are not limited to:
•Theranostics
• Radiopeptides
• PSMA
• Radioembolisation
• Thyroid
All studies must contribute insights into treatments using radionuclides for therapy malignant or benign diseases. Particular focus should be put on effectiveness and safety of the treatments. Reports dealing with diagnosis or with non-radioactive therapy do not fall within the scope of this section and should be submitted to more specialized journals.
Indexed in: CLOCKSS, CrossRef, DOAJ, Google Scholar, OpenAIRE
PMCID: NA
Radionuclide Therapy welcomes submissions of the following article types: Brief Research Report, Case Report, Correction, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Policy and Practice Reviews, Policy Brief, Review and Systematic Review.
All manuscripts must be submitted directly to the section Radionuclide Therapy, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41 (0)21 510 17 00
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41 (0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact nuclearmedicine.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact nuclearmedicine@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org